Fava Giammarco
Giammarco Fava, Division of Gastroenterology, Azienda Ospedaliero-Universitaria, "Ospedali Riuniti", Ancona 60020, Italy.
World J Gastrointest Pathophysiol. 2010 Apr 15;1(1):12-22. doi: 10.4291/wjgp.v1.i1.12.
Cholangiocarcinoma (CC), the malignant tumor of the epithelial cells lining the biliary ducts, has undergone a worldwide increase in incidence and mortality. The malignant transformation of the biliary cells originates from a multistep process evolving through chronic inflammation of the biliary tract to CC. In the last few years several advances have been towards understanding and clarifying the molecular mechanisms implicated in the cholangiocarcinogenesis process. However, many pathophysiologic aspects governing the growth of CC are still undefined. The poor prognosis of this tumor underlines the urgent need to codify the underlying molecular mechanisms involved in the growth and progression of CC in order to design effective preventive measures and valid treatment regimens. This review reports on progresses made in the last few years in clarifying the molecular pathways involved in the process of cholangiocarcinogenesis.
胆管癌(CC)是一种发生于胆管内衬上皮细胞的恶性肿瘤,其发病率和死亡率在全球范围内均呈上升趋势。胆管细胞的恶性转化源于一个多步骤过程,该过程从胆道慢性炎症逐渐发展为胆管癌。在过去几年中,在理解和阐明胆管癌发生过程中涉及的分子机制方面取得了一些进展。然而,许多控制胆管癌生长的病理生理方面仍不明确。这种肿瘤的预后较差,这突出表明迫切需要梳理出参与胆管癌生长和进展的潜在分子机制,以便设计有效的预防措施和合理的治疗方案。本综述报告了过去几年在阐明胆管癌发生过程中涉及的分子途径方面取得的进展。